Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
HR+HER2- High-Risk eBC: Surveying Efficacy Data of CDK4/6i in the Adjuvant Setting
This video was completed prior to Abemaciclib receiving FDA approval on 10/12/21
Login to view comments.
Click here to Login
